Core Laboratories Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	524.73	526.52	523.85	509.79	489.74	470.25
Revenue Growth (YoY)	1.34%	0.51%	2.76%	4.09%	4.14%	-3.49%
Cost of Revenue	420.19	417.59	420.52	399.96	393.66	367.9
Gross Profit	104.54	108.93	103.33	109.83	96.08	102.36
Selling, General & Admin	46.5	45.43	39.77	40.26	38.12	44.17
Depreciation & Amortization Expenses	14.7	14.65	14.95	15.78	17.16	18.52
Other Operating Expenses	-10.59	-7.61	-9.95	-	-	-5.6
Total Operating Expenses	50.6	52.47	44.77	56.04	55.28	57.09
Operating Income	53.94	56.47	58.56	54.64	41.52	45.26
Interest Expense	-10.86	-10.57	-12.37	-13.43	-11.57	-9.15
Other Non-Operating Income (Expense)	-	-	-	-0.85	-0.72	-
Total Non-Operating Income (Expense)	-10.86	-10.57	-12.37	-14.28	-12.29	-9.15
Pretax Income	43.08	45.9	46.19	41.21	29.95	36.11
Provision for Income Taxes	13.51	15.51	14.03	4.19	10.3	15.89
Net Income	29.57	30.39	32.15	37.03	19.66	20.22
Minority Interest in Earnings	0.54	0.72	0.75	0.35	0.21	0.49
Net Income to Common	29.03	29.67	31.4	36.68	19.45	19.73
Net Income Growth	3.60%	-5.51%	-14.38%	88.53%	-1.39%	-
Shares Outstanding (Basic)	46	46	47	47	46	46
Shares Outstanding (Diluted)	47	47	48	48	47	47
Shares Change (YoY)	31.48%	-1.38%	0.34%	1.52%	0.26%	4.98%
EPS (Basic)	0.63	0.64	0.67	0.79	0.42	0.43
EPS (Diluted)	0.61	0.63	0.66	0.77	0.42	0.42
EPS Growth	3.39%	-4.54%	-14.29%	83.33%	-	-
Free Cash Flow	18.44	22.44	43.36	14.21	14.74	23.04
Free Cash Flow Growth	-17.85%	-48.24%	205.14%	-3.60%	-36.02%	-49.90%
Free Cash Flow Per Share	0.39	0.48	0.91	0.30	0.31	0.49
Dividends Per Share	0.040	0.040	0.040	0.040	0.040	0.040
Dividend Growth	-	-	-	-	-	-85.71%
Gross Margin	19.92%	20.69%	19.72%	21.54%	19.62%	21.77%
Operating Margin	10.28%	10.72%	11.18%	10.72%	8.48%	9.63%
Profit Margin	5.64%	5.77%	6.14%	7.26%	4.01%	4.30%
FCF Margin	3.51%	4.26%	8.28%	2.79%	3.01%	4.90%
EBITDA	68.63	71.12	73.51	70.42	58.69	63.78
EBITDA Margin	13.08%	13.51%	14.03%	13.81%	11.98%	13.56%
EBIT	53.94	56.47	58.56	54.64	41.52	45.26
EBIT Margin	10.28%	10.72%	11.18%	10.72%	8.48%	9.63%
Effective Tax Rate	31.36%	33.78%	30.39%	10.16%	34.37%	44.01%

SEC Filings: 10-K · 10-Q